Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus

Infection and Immunity

Volumn 83, Issue 4, 2015, Pages 1587-1597

  Peres, Adam G ^a   Stegen, Camille ^a   Li, Junbin ^a   Xu, An Qi ^a   Levast, Benoit ^a   Surette, Michael G ^a,b   Cousineau, Benoit ^a   Desrosiers, Martin ^a,c   Madrenas, Joaquín ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38; MTOR PROTEIN, HUMAN; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; TLR2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL SURFACE; CELL WALL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

CELL WALL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; INTERLEUKIN-10; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925372819     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02832-14     Document Type: Article

References (53)

1. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. 2005. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 11:868-872. http://dx.doi.org/10.3201/eid1106.040831.
2. Klein E, Smith DL, Laxminarayan R. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13:1840-1846. http://dx.doi.org/10.3201/eid1312.070629.
3. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S, Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173:1970-1978. http://dx.doi.org/10.1001/jamainternmed.2013.10423.
4. Styers D, Sheehan DJ, Hogan P, Sahm DF. 2006. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5:2. http://dx.doi.org/10.1186/1476-0711-5-2.
5. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. 1995. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 115:51-60. http://dx.doi.org/10.1017/S0950268800058118.
6. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF. 2009. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199:1820-1826. http://dx.doi.org/10.1086/599119.
7. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703-705. http://dx.doi.org/10.1016/S0140-6736(04)16897-9.
8. Nashev D, Toshkova K, Salasia SI, Hassan AA, Lammler C, Zschock M. 2004. Distribution of virulence genes of Staphylococcus aureus isolated from stable nasal carriers. FEMS Microbiol Lett 233:45-52. http://dx.doi.org/10.1016/j.femsle.2004.01.032.
9. Lozano C, Gomez-Sanz E, Benito D, Aspiroz C, Zarazaga M, Torres C. 2011. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Int J Med Microbiol 301:500-505. http://dx.doi.org/10.1016/j.ijmm.2011.02.004.
10. Netsvyetayeva I, Fraczek M, Piskorska K, Golas M, Sikora M, Mlynarczyk A, Swoboda-Kopec E, Marusza W, Palmieri B, Iannitti T. 2014. Staphylococcus aureus nasal carriage in Ukraine: antibacterial resistance and virulence factor encoding genes.BMCInfect Dis 14:128. http://dx.doi.org/10.1186/1471-2334-14-128.
11. Marshall C, McBryde E. 2014. The role of Staphylococcus aureus carriage in the pathogenesis of bloodstream infection. BMC Res Notes 7:428. http://dx.doi.org/10.1186/1756-0500-7-428.
12. Brown AF, Leech JM, Rogers TR, McLoughlin RM. 2014. Staphylococcus aureus colonization: modulation of host immune response and impact on human vaccine design. Front Immunol 4:507. http://dx.doi.org/10.3389/fimmu.2013.00507.
13. Peres AG, Madrenas J. 2013. The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns 39:380-388. http://dx.doi.org/10.1016/j.burns.2012.12.008.
14. Fournier B, Philpott DJ. 2005. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 18:521-540. http://dx.doi.org/10.1128/CMR.18.3.521-540.2005.
15. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820. http://dx.doi.org/10.1016/j.cell.2010.01.022.
16. von Bernuth H, Picard C, Jin ZB, Pankla R, Xiao H, Ku CL, Chrabieh M, Ben Mustapha I, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Arostegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yague J, Anton J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Marodi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li XX, Chaussabel D, Puel A, Casanova JL. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-696. http://dx.doi.org/10.1126/science.1158298.
17. Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, Krause JC, Creech CB, Ku CL, Ehl S, Marodi L, Al-Muhsen S, Al-Hajjar S, Al-Ghonaium A, Day-Good NK, Holland SM, Gallin JI, Chapel H, Speert DP, Rodriguez-Gallego C, Colino E, Garty BZ, Roifman C, Hara T, Yoshikawa H, Nonoyama S, Domachowske J, Issekutz AC, Tang M, Smart J, Zitnik SE, Hoarau C, Kumararatne DS, Thrasher AJ, Davies EG, Bethune C, Sirvent N, de Ricaud D, Camcioglu Y, Vasconcelos J, Guedes M, Vitor AB, Rodrigo C, Almazan F, Mendez M, Arostegui JI, Alsina L, Fortuny C, Reichenbach J, Verbsky JW, Bossuyt X, Doffinger R, Abel L, Puel A, Casanova JL. 2010. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) 89:403-425. http://dx.doi.org/10.1097/MD.0b013e3181fd8ec3.
18. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650. http://dx.doi.org/10.1016/j.immuni.2011.05.006.
19. Ip WK, Sokolovska A, Charriere GM, Boyer L, Dejardin S, Cappillino MP, Yantosca LM, Takahashi K, Moore KJ, Lacy-Hulbert A, Stuart LM. 2010. Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J Immunol 184:7071-7081. http://dx.doi.org/10.4049/jimmunol.1000110.
20. Wolf AJ, Arruda A, Reyes CN, Kaplan AT, Shimada T, Shimada K, Arditi M, Liu G, Underhill DM. 2011. Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J Immunol 187:6002-6010. http://dx.doi.org/10.4049/jimmunol.1100232.
21. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J. 2009. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 15:641-648. http://dx.doi.org/10.1038/nm.1965.
22. Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J. 2011. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 204:253-262. http://dx.doi.org/10.1093/infdis/jir276.
23. Wang J, Roderiquez G, Norcross MA. 2012. Control of adaptive immune responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2. Sci Rep 2:606. http://dx.doi.org/10.1038/srep00606.
24. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR, Hooper LV, Schmidt RR, von Aulock S, Radek KA, Huang CM, Ryan AF, Gallo RL. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 15:1377-1382. http://dx.doi.org/10.1038/nm.2062.
25. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974-977. http://dx.doi.org/10.1126/science.1206095.
26. Mele T, Madrenas J. 2010. TLR2 signalling: at the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus. Int J Biochem Cell Biol 42:1066-1071. http://dx.doi.org/10.1016/j.biocel.2010.03.021.
27. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008-1015.
28. Baroja ML, Cieslinski LB, Torphy TJ, Wange RL, Madrenas J. 1999. Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation. J Immunol 162:2016-2023.
29. Feng Y, Chen CJ, Su LH, Hu S, Yu J, Chiu CH. 2008. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev 32:23-37. http://dx.doi.org/10.1111/j.1574-6976.2007.00086.x.
30. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181. http://dx.doi.org/10.1038/nri2711.
31. Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Filloux A, Beyaert R, Flamand V, Vanhaesebroeck B. 2012. The p110delta isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 13:1045-1054. http://dx.doi.org/10.1038/ni.2426.
32. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153:811-816.
33. Arthur JS, Ley SC. 2013. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13:679-692. http://dx.doi.org/10.1038/nri3495.
34. Annane D, Clair B, Salomon J. 2004. Managing toxic shock syndrome with antibiotics. Expert Opin Pharmacother 5:1701-1710. http://dx.doi.org/10.1517/14656566.5.8.1701.
35. Schlievert PM, Kelly JA. 1984. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis 149:471. http://dx.doi.org/10.1093/infdis/149.3.471.
36. Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhlmeier KM, Kolbe T, Stulnig TM, Horl WH, Hengstschlager M, Muller M, Saemann MD. 2008. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29:565-577. http://dx.doi.org/10.1016/j.immuni.2008.08.012.
37. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RA, Moore KJ. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170:477-485. http://dx.doi.org/10.1083/jcb.200501113.
38. Depaolo RW, Tang F, Kim I, Han M, Levin N, Ciletti N, Lin A, Anderson D, Schneewind O, Jabri B. 2008. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrVmediated plague pathogenesis. Cell Host Microbe 4:350-361. http://dx.doi.org/10.1016/j.chom.2008.09.004.
39. DePaolo RW, Kamdar K, Khakpour S, Sugiura Y, Wang W, Jabri B. 2012. A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. J Exp Med 209:1437-1444. http://dx.doi.org/10.1084/jem.20112339.
40. Skabytska Y, Wolbing F, Gunther C, Koberle M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T, Rammensee HG, Schaller M, Rocken M, Gotz F, Biedermann T. 2014. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41:762-775. http://dx.doi.org/10.1016/j.immuni.2014.10.009.
41. Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, O'Neill LA. 2009. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol 183:3642-3651. http://dx.doi.org/10.4049/jimmunol.0901140.
42. Santos-Sierra S, Deshmukh SD, Kalnitski J, Kuenzi P, Wymann MP, Golenbock DT, Henneke P. 2009. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J 28:2018-2027. http://dx.doi.org/10.1038/emboj.2009.158.
43. Hilmi D, Parcina M, Stollewerk D, Ostrop J, Josten M, Meilaender A, Zaehringer U, Wichelhaus TA, Bierbaum G, Heeg K, Wolz C, Bekeredjian-Ding I. 2014. Heterogeneity of host TLR2 stimulation by Staphylocoocus aureus isolates. PLoS One 9:e96416. http://dx.doi.org/10.1371/journal.pone.0096416.
44. Medzhitov R, Schneider DS, Soares MP. 2012. Disease tolerance as a defense strategy. Science 335:936-941. http://dx.doi.org/10.1126/science.1214935.
45. Over B, Ziegler S, Foermer S, Weber AN, Bode KA, Heeg K, Bekeredjian-Ding I. 2013. IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B. Eur J Immunol 43:1630-1642. http://dx.doi.org/10.1002/eji.201243217.
46. Katholnig K, Kaltenecker CC, Hayakawa H, Rosner M, Lassnig C, Zlabinger GJ, Gaestel M, Muller M, Hengstschlager M, Horl WH, Park JM, Saemann MD, Weichhart T. 2013. p38alpha senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J Immunol 190:1519-1527. http://dx.doi.org/10.4049/jimmunol.1202683.
47. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A, Sallusto F. 2012. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484:514-518. http://dx.doi.org/10.1038/nature10957.
48. Ziegler S, Gartner K, Scheuermann U, Zoeller T, Hantzschmann J, Over B, Foermer S, Heeg K, Bekeredjian-Ding I. 2014. Ca(2+)-related signaling events influence TLR9-induced IL-10 secretion in human B cells. Eur J Immunol 44:1285-1298. http://dx.doi.org/10.1002/eji.201343994.
49. Parcina M, Miranda-Garcia MA, Durlanik S, Ziegler S, Over B, Georg P, Foermer S, Ammann S, Hilmi D, Weber KJ, Schiller M, Heeg K, Schneider-Brachert W, Gotz F, Bekeredjian-Ding I. 2013. Pathogentriggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus. J Immunol 190: 1591-1602. http://dx.doi.org/10.4049/jimmunol.1201222.
50. Van Dyken SJ, Locksley RM. 2013. Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31:317-343. http://dx.doi.org/10.1146/annurev-immunol-032712-095906.
51. Grainger JR, Wohlfert EA, Fuss IJ, Bouladoux N, Askenase MH, Legrand F, Koo LY, Brenchley JM, Fraser ID, Belkaid Y. 2013. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 19:713-721. http://dx.doi.org/10.1038/nm.3189.
52. Szkaradkiewicz A, Karpinski TM, Zeidler A, Szkaradkiewicz AK, Masiuk H, Giedrys-Kalemba S. 2012. Cytokine response in patients with chronic infections caused by Staphylococcus aureus strains and diversification of their Agr system classes. Eur J Clin Microbiol Infect Dis 31:2809-2815. http://dx.doi.org/10.1007/s10096-012-1633-7.
53. Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G. 2012. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 206:1604-1611. http://dx.doi.org/10.1093/infdis/jis552.